APA (7th ed.) Citation

Mikhaylova, I. N., Treshalina, N. M., Shubina, I. Z., Manina, I. V., Kiselevsky, M. V., & Lukashev, A. N. (2021). Antitumor proteinkinase inhibitor imatinib may be regarded as a potential correcting agent for COVID-19 associated pulmonary fibrosis. ABV-press.

Chicago Style (17th ed.) Citation

Mikhaylova, I. N., N. M. Treshalina, I. Zh Shubina, I. V. Manina, M. V. Kiselevsky, and A. N. Lukashev. Antitumor Proteinkinase Inhibitor Imatinib May Be Regarded as a Potential Correcting Agent for COVID-19 Associated Pulmonary Fibrosis. ABV-press, 2021.

MLA (9th ed.) Citation

Mikhaylova, I. N., et al. Antitumor Proteinkinase Inhibitor Imatinib May Be Regarded as a Potential Correcting Agent for COVID-19 Associated Pulmonary Fibrosis. ABV-press, 2021.